Soleno Therapeutics (SLNO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec11

LifeSci Capital Maintains Buy Rating on Soleno Therapeutics

19:36

Soleno Therapeutics shares open higher, reports strong quarterly earnings

18:39

Nov21

Westfield Capital Management Increased Its Stake in Soleno Therapeutics

14:29

Nov18

Soleno Therapeutics Launches VYKAT XR for Overeating

16:47

Nov16

Soleno Therapeutics Announces Share Repurchase

10:42

Nov11

Soleno Therapeutics Signs $100 Million Accelerated Stock Repurchase Agreement

12:30

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 66.02 M, Net Income 26.01 M, EPS 0.47

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 32.66 M, Net Income -4.708 M, EPS -0.0932

May7

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -43.77 M, EPS -0.9479

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More